This study aimed to demonstrate stromal CD10 immunoreactivity in gastric adenocarcinoma and investigate its association with some clinicopathological parameters, including the patient's age, gender, tumor type, lymphovascular invasion, and lymph node status as well as tumor grade and stage. This evidence concerns the gene MME and gastric adenocarcinoma.